Comparative ocular safety of dupilumab and oral Janus kinase inhibitors in atopic dermatitis: A real-world propensity-matched analysis. [PDF]
Adler R +8 more
europepmc +1 more source
Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors. [PDF]
Sahin G, Aydin F, Pancar Yuksel E.
europepmc +1 more source
Next-generation Janus kinase inhibitors: Integrating synthetic innovation, structural biology, and computational design for precision drug discovery. [PDF]
Karunakar KK +4 more
europepmc +1 more source
Janus kinase inhibitors in pulmonary and extra-pulmonary sarcoidosis: A case series and a systematic review of the literature. [PDF]
Quaggetto M +7 more
europepmc +1 more source
Janus Kinase Inhibitors as A Breakthrough Treatment for Refractory Dissecting Cellulitis of the Scalp. [PDF]
Al-Mamoori A +3 more
europepmc +1 more source
A Systematic Review of the Use of Janus Kinase Inhibitors in Large Vessel Vasculitis. [PDF]
Chay T +6 more
europepmc +1 more source
Janus kinase inhibitors - a role for the treatment of cutaneous T-cell lymphomas? [PDF]
Packer SE, Brunner PM.
europepmc +1 more source
Glucocorticoid sparing in rheumatoid arthritis patients treated with Janus kinase inhibitors: insights from the Japanese patient registry. [PDF]
Shoda H +4 more
europepmc +1 more source
Janus Kinase Inhibitors During Pregnancy and Adverse Drug Reactions: A Pharmacovigilance Disproportionality Analysis in VigiBase. [PDF]
Abolhassani N +7 more
europepmc +1 more source
Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactation. [PDF]
Werfel T +39 more
europepmc +1 more source

